HeartSciences (HSCS) Competitors $3.68 -0.11 (-2.78%) Closing price 07/3/2025 03:48 PM EasternExtended Trading$3.55 -0.12 (-3.29%) As of 07/3/2025 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. PSTV, IRIX, XAIR, MHUA, DHAI, LYRA, INBS, PAVM, WOK, and IINNShould you be buying HeartSciences stock or one of its competitors? The main competitors of HeartSciences include Plus Therapeutics (PSTV), IRIDEX (IRIX), Beyond Air (XAIR), Meihua International Medical Technologies (MHUA), DIH Holding US (DHAI), Lyra Therapeutics (LYRA), Intelligent Bio Solutions (INBS), PAVmed (PAVM), WORK Medical Technology Group (WOK), and Inspira Technologies OXY B.H.N. (IINN). These companies are all part of the "medical equipment" industry. HeartSciences vs. Its Competitors Plus Therapeutics IRIDEX Beyond Air Meihua International Medical Technologies DIH Holding US Lyra Therapeutics Intelligent Bio Solutions PAVmed WORK Medical Technology Group Inspira Technologies OXY B.H.N. HeartSciences (NASDAQ:HSCS) and Plus Therapeutics (NASDAQ:PSTV) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership. Is HSCS or PSTV more profitable? HeartSciences has a net margin of 0.00% compared to Plus Therapeutics' net margin of -520.90%. Plus Therapeutics' return on equity of 0.00% beat HeartSciences' return on equity.Company Net Margins Return on Equity Return on Assets HeartSciencesN/A -178.80% -109.28% Plus Therapeutics -520.90%N/A -202.73% Do institutionals & insiders hold more shares of HSCS or PSTV? 17.2% of HeartSciences shares are held by institutional investors. Comparatively, 3.3% of Plus Therapeutics shares are held by institutional investors. 1.8% of HeartSciences shares are held by insiders. Comparatively, 3.8% of Plus Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media prefer HSCS or PSTV? In the previous week, Plus Therapeutics had 1 more articles in the media than HeartSciences. MarketBeat recorded 2 mentions for Plus Therapeutics and 1 mentions for HeartSciences. HeartSciences' average media sentiment score of 0.00 beat Plus Therapeutics' score of -0.21 indicating that HeartSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Plus Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings & valuation, HSCS or PSTV? HeartSciences has higher earnings, but lower revenue than Plus Therapeutics. HeartSciences is trading at a lower price-to-earnings ratio than Plus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeartSciences$20K198.45-$6.61M-$7.48-0.49Plus Therapeutics$5.82M2.59-$12.98M-$2.94-0.10 Do analysts rate HSCS or PSTV? HeartSciences presently has a consensus target price of $13.00, indicating a potential upside of 253.74%. Plus Therapeutics has a consensus target price of $10.83, indicating a potential upside of 3,559.91%. Given Plus Therapeutics' higher probable upside, analysts clearly believe Plus Therapeutics is more favorable than HeartSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Plus Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility & risk, HSCS or PSTV? HeartSciences has a beta of 2.57, indicating that its share price is 157% more volatile than the S&P 500. Comparatively, Plus Therapeutics has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. SummaryHeartSciences beats Plus Therapeutics on 8 of the 14 factors compared between the two stocks. Get HeartSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeartSciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.86M$2.04B$5.55B$9.05BDividend YieldN/AN/A5.24%4.01%P/E RatioN/A16.6019.5920.21Price / Sales198.4515.98418.25119.02Price / CashN/A55.8836.8958.10Price / Book0.338.708.035.67Net Income-$6.61M-$62.39M$3.18B$249.21M7 Day Performance0.41%2.58%2.93%3.28%1 Month Performance2.37%3.01%3.75%5.55%1 Year Performance-16.67%4.06%35.20%21.09% HeartSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeartSciences1.6789 of 5 stars$3.68-2.8%$13.00+253.7%-22.6%$3.86M$20K0.0010News CoveragePSTVPlus Therapeutics1.6993 of 5 stars$0.31-10.8%$10.83+3,393.5%-80.7%$15.81MN/A-0.1120IRIXIRIDEX0.5419 of 5 stars$0.89+0.9%N/A-55.7%$14.95M$48.67M-2.07120News CoverageXAIRBeyond Air3.9175 of 5 stars$0.17+0.4%$1.50+767.1%-69.7%$14.94M$3.71M-0.2270MHUAMeihua International Medical Technologies1.1754 of 5 stars$0.42+4.5%N/A-53.3%$13.33M$96.90M0.00620News CoveragePositive NewsGap DownDHAIDIH Holding US0.6867 of 5 stars$0.25+3.1%N/A-92.1%$11.96M$64.47M-0.84N/AGap DownLYRALyra Therapeutics2.0658 of 5 stars$8.90-0.7%$100.00+1,023.6%-35.6%$11.84M$1.53M-0.1550Analyst UpgradeINBSIntelligent Bio Solutions0.3144 of 5 stars$1.68-2.3%N/A+1.1%$11.61M$3.11M0.0010PAVMPAVmed3.9541 of 5 stars$0.62+2.6%$19.00+2,983.9%-15.7%$10.53M$2.99M0.8790WOKWORK Medical Technology GroupN/A$0.71+2.9%N/AN/A$10.36M$11.51M0.00226Positive NewsIINNInspira Technologies OXY B.H.N.2.8526 of 5 stars$0.81-4.3%$2.00+145.8%-9.6%$10.27MN/A0.0020 Related Companies and Tools Related Companies Plus Therapeutics Competitors IRIDEX Competitors Beyond Air Competitors Meihua International Medical Technologies Competitors DIH Holding US Competitors Lyra Therapeutics Competitors Intelligent Bio Solutions Competitors PAVmed Competitors WORK Medical Technology Group Competitors Inspira Technologies OXY B.H.N. Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSCS Stock Alerts